B93. BREAKTHROUGHS IN PEDIATRIC AND ADULT ASTHMA CLINICAL TRIALS

An Add-on Reliever-Triggered Inhaled Corticosteroid Strategy Reduces Severe Asthma Exacerbations in a Real-World Study of African American/Black and Hispanic/Latinx Patients with Asthma

Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3416 J. Cardet, W. Pace, J. Carroll, A. Fuhlbrigge, L. She, F. Rockhold, N. Maher, M. Fagan, V. Forth, P. Arias Hernandez, J. Kruse, B. Manning, J. Rodriguez-Louis, J. Shields, B. Ericson, A. Colon-Moya, T. Coyne-Beasley, G. M. Hammer, B. Kaplan, S. Madison, C. Rand, J. Robles, O. Thompson, M. Wechsler, J. Wisnivesky, M. McKee, S. Jariwala, E. Jerschow, P. Busse, D. Kaelber, S. Nazario, M. Hernandez, A. Apter, K.-L. Chang, V. Pinto-Plata, P. Stranges, L. Hurley, J. Trevor, T. Casale, G. Chupp, I. Riley, K. Shenoy, M. Pasarica, R.A. Calderon Candelario, H. Tapp, A. Baydur, B. Yawn, E. Israel

Exacerbation Burden and Biologic Outcomes in US Patients with Severe Asthma and Significant Smoking History or COPD: Results from the CHRONICLE Study

Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3417 N. Lugogo, R. Panettieri, B. Chipps, J. Trevor, D. Carstens, A. Lindsley, C. Ambrose

FeNO as a Potential Prognostic and Predictive Marker of Lung Function Decline in Patients with Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA QUEST

Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3418 I. Pavord, G. Brusselle, D. Jackson, C. Brightling, A. Papi, J. Maspero, K. Rabe, S. Korn, M. Zhang, M. Djandji, M. Hardin, L. De Prado Gomez, J. Jacob-Nara, P. Rowe